nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—TF—urine—polycystic ovary syndrome	0.0957	0.231	CbGeAlD
Bismuth Subsalicylate—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0649	0.156	CbGeAlD
Bismuth Subsalicylate—TF—embryo—polycystic ovary syndrome	0.0309	0.0746	CbGeAlD
Bismuth Subsalicylate—TF—uterus—polycystic ovary syndrome	0.0209	0.0503	CbGeAlD
Bismuth Subsalicylate—TF—adipose tissue—polycystic ovary syndrome	0.0204	0.0492	CbGeAlD
Bismuth Subsalicylate—TF—adrenal gland—polycystic ovary syndrome	0.0183	0.0441	CbGeAlD
Bismuth Subsalicylate—TF—female gonad—polycystic ovary syndrome	0.0171	0.0411	CbGeAlD
Bismuth Subsalicylate—TF—vagina—polycystic ovary syndrome	0.017	0.0409	CbGeAlD
Bismuth Subsalicylate—TF—endocrine gland—polycystic ovary syndrome	0.0159	0.0382	CbGeAlD
Bismuth Subsalicylate—Upset stomach—Metformin—polycystic ovary syndrome	0.0127	0.122	CcSEcCtD
Bismuth Subsalicylate—Heartburn—Metformin—polycystic ovary syndrome	0.0121	0.116	CcSEcCtD
Bismuth Subsalicylate—ALB—adrenal gland—polycystic ovary syndrome	0.00952	0.0229	CbGeAlD
Bismuth Subsalicylate—PTGS2—embryo—polycystic ovary syndrome	0.00877	0.0211	CbGeAlD
Bismuth Subsalicylate—Lightheadedness—Metformin—polycystic ovary syndrome	0.00745	0.0714	CcSEcCtD
Bismuth Subsalicylate—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00719	0.0173	CbGeAlD
Bismuth Subsalicylate—PTGS1—endometrium—polycystic ovary syndrome	0.00671	0.0162	CbGeAlD
Bismuth Subsalicylate—PTGS2—endometrium—polycystic ovary syndrome	0.00642	0.0155	CbGeAlD
Bismuth Subsalicylate—PTGS1—uterus—polycystic ovary syndrome	0.00619	0.0149	CbGeAlD
Bismuth Subsalicylate—Lethargy—Metformin—polycystic ovary syndrome	0.00617	0.0591	CcSEcCtD
Bismuth Subsalicylate—PTGS1—pituitary gland—polycystic ovary syndrome	0.00608	0.0146	CbGeAlD
Bismuth Subsalicylate—PTGS1—adipose tissue—polycystic ovary syndrome	0.00605	0.0146	CbGeAlD
Bismuth Subsalicylate—PTGS2—uterus—polycystic ovary syndrome	0.00591	0.0142	CbGeAlD
Bismuth Subsalicylate—PTGS2—pituitary gland—polycystic ovary syndrome	0.00581	0.014	CbGeAlD
Bismuth Subsalicylate—PTGS2—adipose tissue—polycystic ovary syndrome	0.00578	0.0139	CbGeAlD
Bismuth Subsalicylate—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00552	0.0529	CcSEcCtD
Bismuth Subsalicylate—PTGS1—adrenal gland—polycystic ovary syndrome	0.00543	0.0131	CbGeAlD
Bismuth Subsalicylate—PTGS2—adrenal gland—polycystic ovary syndrome	0.00519	0.0125	CbGeAlD
Bismuth Subsalicylate—PTGS1—female gonad—polycystic ovary syndrome	0.00506	0.0122	CbGeAlD
Bismuth Subsalicylate—PTGS1—vagina—polycystic ovary syndrome	0.00503	0.0121	CbGeAlD
Bismuth Subsalicylate—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00501	0.048	CcSEcCtD
Bismuth Subsalicylate—PTGS2—female gonad—polycystic ovary syndrome	0.00484	0.0117	CbGeAlD
Bismuth Subsalicylate—PTGS2—vagina—polycystic ovary syndrome	0.00481	0.0116	CbGeAlD
Bismuth Subsalicylate—PTGS1—endocrine gland—polycystic ovary syndrome	0.00471	0.0113	CbGeAlD
Bismuth Subsalicylate—Drowsiness—Metformin—polycystic ovary syndrome	0.00466	0.0447	CcSEcCtD
Bismuth Subsalicylate—PTGS2—endocrine gland—polycystic ovary syndrome	0.0045	0.0108	CbGeAlD
Bismuth Subsalicylate—Hepatitis—Metformin—polycystic ovary syndrome	0.00418	0.0401	CcSEcCtD
Bismuth Subsalicylate—Erythema—Metformin—polycystic ovary syndrome	0.00364	0.0349	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Metformin—polycystic ovary syndrome	0.00356	0.0342	CcSEcCtD
Bismuth Subsalicylate—Oedema—Metformin—polycystic ovary syndrome	0.00297	0.0285	CcSEcCtD
Bismuth Subsalicylate—Infection—Metformin—polycystic ovary syndrome	0.00295	0.0283	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Metformin—polycystic ovary syndrome	0.00283	0.0272	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Metformin—polycystic ovary syndrome	0.00264	0.0253	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Metformin—polycystic ovary syndrome	0.00261	0.0251	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Metformin—polycystic ovary syndrome	0.00258	0.0248	CcSEcCtD
Bismuth Subsalicylate—Constipation—Metformin—polycystic ovary syndrome	0.00254	0.0244	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00245	0.0235	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Metformin—polycystic ovary syndrome	0.00236	0.0226	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Metformin—polycystic ovary syndrome	0.0021	0.0202	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Metformin—polycystic ovary syndrome	0.00203	0.0195	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Metformin—polycystic ovary syndrome	0.00196	0.0188	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Metformin—polycystic ovary syndrome	0.00189	0.0181	CcSEcCtD
Bismuth Subsalicylate—Rash—Metformin—polycystic ovary syndrome	0.00187	0.018	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Metformin—polycystic ovary syndrome	0.00187	0.0179	CcSEcCtD
Bismuth Subsalicylate—Headache—Metformin—polycystic ovary syndrome	0.00186	0.0178	CcSEcCtD
Bismuth Subsalicylate—Nausea—Metformin—polycystic ovary syndrome	0.00176	0.0169	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00104	0.00216	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—CRP—polycystic ovary syndrome	0.00103	0.00215	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00103	0.00214	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00102	0.00212	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000983	0.00204	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000979	0.00204	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000979	0.00204	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000977	0.00203	CbGpPWpGaD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000971	0.00202	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000962	0.002	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.000934	0.00194	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000928	0.00193	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000926	0.00193	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—MTHFR—polycystic ovary syndrome	0.000883	0.00184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.000875	0.00182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000869	0.00181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000867	0.0018	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—INS—polycystic ovary syndrome	0.000863	0.0018	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00085	0.00177	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000846	0.00176	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—CRP—polycystic ovary syndrome	0.00084	0.00175	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.000825	0.00172	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00082	0.00171	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000798	0.00166	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000795	0.00165	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—SERPINE1—polycystic ovary syndrome	0.000793	0.00165	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000778	0.00162	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000777	0.00162	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000777	0.00162	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000777	0.00162	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—GP1BB—polycystic ovary syndrome	0.000764	0.00159	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000742	0.00154	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000732	0.00152	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IGF1—polycystic ovary syndrome	0.000731	0.00152	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—AKT2—polycystic ovary syndrome	0.00073	0.00152	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—INS—polycystic ovary syndrome	0.000702	0.00146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000702	0.00146	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000694	0.00144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00069	0.00143	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000685	0.00143	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.000667	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000661	0.00137	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000651	0.00135	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—SERPINE1—polycystic ovary syndrome	0.000645	0.00134	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.000638	0.00133	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000633	0.00132	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000631	0.00131	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000629	0.00131	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000629	0.00131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000617	0.00128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.000604	0.00126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000604	0.00126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000603	0.00125	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000598	0.00124	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000589	0.00123	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—IGF1—polycystic ovary syndrome	0.000582	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000575	0.0012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.000572	0.00119	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000562	0.00117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000558	0.00116	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—polycystic ovary syndrome	0.000555	0.00115	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—SERPINE1—polycystic ovary syndrome	0.000553	0.00115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000551	0.00115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.000551	0.00115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000544	0.00113	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	0.000527	0.0011	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000527	0.0011	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000514	0.00107	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000513	0.00107	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000513	0.00107	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PDE3B—polycystic ovary syndrome	0.000512	0.00107	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.000511	0.00106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000501	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000501	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000499	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000479	0.000996	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—VEGFA—polycystic ovary syndrome	0.000477	0.000993	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000476	0.000991	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000468	0.000973	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000457	0.00095	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000446	0.000928	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000444	0.000923	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RACGAP1—polycystic ovary syndrome	0.000439	0.000912	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000438	0.000911	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000438	0.000911	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000436	0.000907	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000436	0.000907	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000432	0.000899	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000419	0.000872	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000417	0.000868	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000413	0.000858	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000407	0.000847	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000405	0.000843	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000398	0.000827	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	0.000387	0.000806	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	0.00038	0.000791	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00038	0.00079	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	0.000377	0.000785	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000371	0.000773	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000369	0.000768	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000365	0.00076	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	0.000362	0.000754	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000361	0.000751	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000359	0.000747	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	0.000354	0.000737	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SUOX—polycystic ovary syndrome	0.000354	0.000737	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000352	0.000733	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00035	0.000727	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000346	0.00072	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000346	0.00072	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000346	0.00072	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000333	0.000692	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.00033	0.000687	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	0.000329	0.000685	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000328	0.000681	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000327	0.000679	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000322	0.000669	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000313	0.000652	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	0.000307	0.000638	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000301	0.000627	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.0003	0.000625	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000294	0.000613	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000294	0.000612	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.00029	0.000603	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000285	0.000593	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000281	0.000584	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	0.00028	0.000582	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TEAD2—polycystic ovary syndrome	0.00028	0.000582	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000279	0.000581	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000278	0.000578	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000275	0.000572	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000269	0.00056	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.000268	0.000557	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000265	0.000551	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000263	0.000548	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000262	0.000546	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000259	0.000539	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000258	0.000537	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000258	0.000537	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000256	0.000533	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.00025	0.000521	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000249	0.000519	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000245	0.00051	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000244	0.000507	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000242	0.000504	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000238	0.000496	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.000235	0.000488	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000234	0.000488	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000234	0.000486	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000232	0.000482	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.00023	0.000478	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000223	0.000464	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000223	0.000464	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000222	0.000463	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00022	0.000459	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000216	0.00045	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000213	0.000444	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—STAR—polycystic ovary syndrome	0.000212	0.000441	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000212	0.000441	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000212	0.00044	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00021	0.000436	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000209	0.000435	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000208	0.000433	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—GNAS—polycystic ovary syndrome	0.000206	0.000428	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000203	0.000423	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.0002	0.000416	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000199	0.000414	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000199	0.000413	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000198	0.000411	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000196	0.000408	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000195	0.000405	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000192	0.0004	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.00019	0.000395	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMMR—polycystic ovary syndrome	0.000189	0.000393	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000187	0.000388	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000184	0.000382	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	0.00018	0.000375	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000178	0.000371	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000178	0.00037	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000177	0.000369	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000177	0.000368	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000174	0.000362	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000172	0.000357	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000169	0.000352	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000169	0.000351	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000165	0.000344	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LHB—polycystic ovary syndrome	0.000165	0.000342	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	0.000161	0.000335	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000159	0.000331	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000159	0.000331	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000158	0.000329	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000157	0.000326	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000156	0.000324	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	0.000156	0.000324	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000155	0.000322	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.000149	0.00031	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000148	0.000308	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000147	0.000305	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000146	0.000303	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000145	0.000303	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	0.000143	0.000298	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PRL—polycystic ovary syndrome	0.00014	0.000291	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—RRM2—polycystic ovary syndrome	0.000139	0.000289	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—YAP1—polycystic ovary syndrome	0.000134	0.000278	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF1—polycystic ovary syndrome	0.000133	0.000277	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT2—polycystic ovary syndrome	0.000133	0.000277	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.00013	0.00027	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NAMPT—polycystic ovary syndrome	0.000129	0.000267	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000128	0.000266	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	0.000127	0.000264	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000126	0.000263	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.000126	0.000263	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000126	0.000262	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000124	0.000257	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000123	0.000255	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	0.00012	0.000249	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	0.000118	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000117	0.000244	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.000117	0.000244	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000115	0.00024	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.000115	0.000239	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000109	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.000104	0.000215	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000103	0.000214	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TH—polycystic ovary syndrome	0.000102	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	9.93e-05	0.000207	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IRS2—polycystic ovary syndrome	9.85e-05	0.000205	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	9.82e-05	0.000204	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	9.34e-05	0.000194	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	9.31e-05	0.000194	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	8.86e-05	0.000184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—POMC—polycystic ovary syndrome	8.74e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	8.7e-05	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—INS—polycystic ovary syndrome	8.69e-05	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	8.68e-05	0.00018	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IRS1—polycystic ovary syndrome	8.6e-05	0.000179	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GNAS—polycystic ovary syndrome	8.34e-05	0.000173	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—INS—polycystic ovary syndrome	8.24e-05	0.000171	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT2—polycystic ovary syndrome	7.96e-05	0.000166	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NCOR1—polycystic ovary syndrome	7.94e-05	0.000165	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	7.57e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	7.53e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	7.03e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTHFR—polycystic ovary syndrome	7.02e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—POMC—polycystic ovary syndrome	6.94e-05	0.000144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—INS—polycystic ovary syndrome	6.9e-05	0.000144	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARG—polycystic ovary syndrome	5.69e-05	0.000118	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—POMC—polycystic ovary syndrome	5.61e-05	0.000117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—INS—polycystic ovary syndrome	5.58e-05	0.000116	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—polycystic ovary syndrome	3.6e-05	7.49e-05	CbGpPWpGaD
